Guangzhou LBP Medicine Science & Technology Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

-21.6%

Groei van de winst

-27.8%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie	16.0%
Inkomstengroei	8.4%
Rendement op eigen vermogen	2.0%
Nettomarge	6.5%
Laatste winstupdate	30 Sep 2024

Recente prestatie-updates uit het verleden

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Nov 06

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 29

Recent updates

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Nov 06

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon

Sep 30

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 29

Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Apr 23

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

Mar 09

Opbrengsten en kosten

Hoe Guangzhou LBP Medicine Science & Technology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

SHSE:688393 Opbrengsten, kosten en inkomsten (CNY Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
30 Sep 24	495	32	276	48
30 Jun 24	514	38	280	57
31 Mar 24	508	40	272	59
31 Dec 23	497	40	263	63
30 Sep 23	488	37	263	65
30 Jun 23	476	26	274	64
31 Mar 23	478	31	272	65
31 Dec 22	507	43	265	67
30 Sep 22	486	49	265	58
30 Jun 22	469	64	245	62
31 Mar 22	460	73	237	55
31 Dec 21	439	80	234	46
30 Sep 21	438	93	229	45
30 Jun 21	443	103	229	32
31 Mar 21	436	102	222	30
31 Dec 20	375	85	192	28
30 Sep 20	370	80	185	26
30 Jun 20	344	75	172	25
31 Mar 20	323	68	171	23
31 Dec 19	355	74	190	22
31 Dec 18	306	61	165	16
31 Dec 17	260	48	142	15
31 Dec 13	143	38	57	0

Guangzhou LBP Medicine Science & Technology Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Third quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.21 in 3Q 2023)

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.46 in FY 2022)

Recent updates

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Third quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.21 in 3Q 2023)

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 27%

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon

New minor risk - Earnings quality

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.46 in FY 2022)

Guangzhou LBP Medicine Science & Technology Co., Ltd., Annual General Meeting, May 15, 2024

Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Investor sentiment deteriorates as stock falls 18%

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Investor sentiment improves as stock rises 19%

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.46 in FY 2022)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.09 in 3Q 2022)

Less than half of directors are independent

Investor sentiment deteriorates as stock falls 21%

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023

Full year 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.85 in FY 2021)

Investor sentiment improves as stock rises 19%

Full year 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.85 in FY 2021)

Investor sentiment improves as stock rises 16%

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.09 (vs CN¥0.25 in 3Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.29 in 1Q 2021)

Full year 2021 earnings released: EPS: CN¥0.86 (vs CN¥1.09 in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.43 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.26 (vs CN¥0.33 in 2Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥1.09 (vs CN¥1.06 in FY 2019)

New 90-day low: CN¥34.43

New 90-day low: CN¥39.97

New 90-day low: CN¥42.73

Third quarter earnings released

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q3, 2020 Results on Oct 22, 2020

Opbrengsten en kosten

Inkomsten en omzetgeschiedenis

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Rendement op eigen vermogen

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden